| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 267.91M | 292.44M | 314.84M | 313.77M | 163.97M |
| Gross Profit | 66.06M | 225.17M | 38.76M | 24.72M | 5.89M |
| EBITDA | 26.88M | 31.16M | -20.09M | 17.70M | -36.66M |
| Net Income | 23.19M | -17.79M | -73.51M | -28.59M | -105.28M |
Balance Sheet | |||||
| Total Assets | 683.19M | 642.94M | 712.01M | 823.41M | 716.49M |
| Cash, Cash Equivalents and Short-Term Investments | 76.53M | 15.61M | 48.17M | 39.96M | 49.97M |
| Total Debt | 143.06M | 148.65M | 189.95M | 231.15M | 187.15M |
| Total Liabilities | 474.48M | 462.68M | 520.86M | 561.68M | 425.81M |
| Stockholders Equity | 201.58M | 172.82M | 186.83M | 256.05M | 286.01M |
Cash Flow | |||||
| Free Cash Flow | 31.71M | 11.51M | -29.58M | 19.11M | 119.80M |
| Operating Cash Flow | 35.25M | 19.21M | -28.71M | 22.88M | 125.43M |
| Investing Cash Flow | -3.23M | 15.51M | 43.60M | 27.22M | -29.07M |
| Financing Cash Flow | -5.24M | -42.74M | -29.49M | -28.51M | -98.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$3.27B | 5.39 | 8.78% | 3.59% | 17.33% | 65.22% | |
67 Neutral | HK$383.60M | 2.38 | 29.99% | ― | -5.34% | 400.80% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | HK$400.59M | 3.80 | 12.68% | ― | -7.16% | ― | |
48 Neutral | HK$390.18M | -0.87 | -11.00% | ― | 4.50% | -1232.04% | |
43 Neutral | HK$263.46M | -17.00 | -10.68% | ― | 58.74% | 56.30% | |
41 Neutral | HK$8.66B | 275.81 | 1.06% | ― | 50.13% | ― |